Transarterial chemoembolization alone or followed by bevacizumab for treatment of colorectal liver metastases

AIMS: Bevacizumab (B) in association with systemic chemotherapy is commonly used for the treatment of colorectal cancer liver metastases. The aim of this study was to monitor tumor response, overall survival (OS) and progression-free survival (PFS) of patients with colorectal cancer liver metastases...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiorentini, Giammaria, Sarti, Donatella, Nardella, Michele, Inchingolo, Riccardo, Nestola, Massimiliano, Rebonato, Alberto, Fiorentini, Caterina, Aliberti, Camillo, Nani, Roberto, Guadagni, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577510/
https://www.ncbi.nlm.nih.gov/pubmed/34765108
http://dx.doi.org/10.2217/hep-2020-0031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577510/
https://www.ncbi.nlm.nih.gov/pubmed/34765108
http://dx.doi.org/10.2217/hep-2020-0031

Ejemplares similares